These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8279748)

  • 1. A locus on chromosome 17p13.3, associated with a high S-phase index is distinct from the p53 gene in breast cancer.
    Liscia DS; Venesio T; Diella F; Bernardi A; Cappa AP; Callahan R; Merlo GR
    Ann N Y Acad Sci; 1993 Nov; 698():120-5. PubMed ID: 8279748
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for a second tumor suppressor gene on 17p linked to high S-phase index in primary human breast carcinomas.
    Merlo GR; Venesio T; Bernardi A; Cropp CS; Diella F; Cappa AP; Callahan R; Liscia DS
    Cancer Genet Cytogenet; 1994 Sep; 76(2):106-11. PubMed ID: 7923057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In primary human breast carcinomas mutations in exons 5 and 6 of the p53 gene are associated with a high S-phase index.
    Merlo GR; Bernardi A; Diella F; Venesio T; Cappa AP; Callahan R; Liscia DS
    Int J Cancer; 1993 Jun; 54(4):531-5. PubMed ID: 8514444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
    Negrini M; Sabbioni S; Haldar S; Possati L; Castagnoli A; Corallini A; Barbanti-Brodano G; Croce CM
    Cancer Res; 1994 Apr; 54(7):1818-24. PubMed ID: 8137297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in p53 as potential molecular markers for human breast cancer.
    Runnebaum IB; Nagarajan M; Bowman M; Soto D; Sukumar S
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10657-61. PubMed ID: 1961733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of retinoblastoma gene (RB1) is associated with deletions at the 17p13.3 chromosome and S-phase index in human breast cancer.
    Venesio T; Bernardi A; Scordamaglia A; Ferrero P; Salvego M; Cappa AP; Liscia DS
    Ann N Y Acad Sci; 1996 Apr; 784():462-6. PubMed ID: 8651599
    [No Abstract]   [Full Text] [Related]  

  • 8. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of the p53 gene and loss of heterozygosity at chromosome 17p13.1 are associated with increased survivin expression in breast cancer.
    Tsuji N; Furuse K; Asanuma K; Furuya M; Kondoh K; Kamagata C; Sasaki M; Kobayashi D; Yagihashi A; Takahashi H; Watanabe N
    Breast Cancer Res Treat; 2004 Sep; 87(1):23-31. PubMed ID: 15377848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene.
    Liscia DS; Morizio R; Venesio T; Palenzona C; Donadio M; Callahan R
    Br J Cancer; 1999 May; 80(5-6):821-6. PubMed ID: 10360661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer.
    Chen LC; Neubauer A; Kurisu W; Waldman FM; Ljung BM; Goodson W; Goldman ES; Moore D; Balazs M; Liu E
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3847-51. PubMed ID: 1673792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material.
    Karameris AM; Worthy E; Gorgoulis VG; Quezado M; Anastassiades OT
    J Pathol; 1995 Aug; 176(4):361-72. PubMed ID: 7562251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
    Futreal PA; Cochran C; Marks JR; Iglehart JD; Zimmerman W; Barrett JC; Wiseman RW
    Cancer Res; 1994 Apr; 54(7):1791-4. PubMed ID: 7511052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutations occur in aggressive breast cancer.
    Mazars R; Spinardi L; BenCheikh M; Simony-Lafontaine J; Jeanteur P; Theillet C
    Cancer Res; 1992 Jul; 52(14):3918-23. PubMed ID: 1617667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional evidence for a breast cancer growth suppressor gene on chromosome 17.
    Casey G; Plummer S; Hoeltge G; Scanlon D; Fasching C; Stanbridge EJ
    Hum Mol Genet; 1993 Nov; 2(11):1921-7. PubMed ID: 8281156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic changes in breast carcinomas in an Icelandic population.
    Eyfjörd JE; Thorlacius S
    Pharmacogenetics; 1992 Dec; 2(6):309-16. PubMed ID: 1306132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers.
    Aberle H; Bierkamp C; Torchard D; Serova O; Wagner T; Natt E; Wirsching J; Heidkämper C; Montagna M; Lynch HT
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6384-8. PubMed ID: 7604000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma.
    Thorlacius S; Jonasdottir O; Eyfjord JE
    Anticancer Res; 1991; 11(4):1501-7. PubMed ID: 1746906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.
    Thompson AM; Crichton DN; Elton RA; Clay MF; Chetty U; Steel CM
    Br J Cancer; 1998 Mar; 77(5):797-800. PubMed ID: 9514060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers.
    Konishi H; Takahashi T; Kozaki K; Yatabe Y; Mitsudomi T; Fujii Y; Sugiura T; Matsuda H; Takahashi T; Takahashi T
    Oncogene; 1998 Oct; 17(16):2095-100. PubMed ID: 9798680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.